Deborah J. Andrews

Deborah J. Andrews

Director/Board Member at LINEAGE CELL THERAPEUTICS, INC.

Net worth: 17 292 $ as of 2024-04-29

66 year
Health Technology
Commercial Services
Producer Manufacturing

Profile

Deborah J.
Andrews
is an Independent Director at Lineage Cell Therapeutics, Inc. since 2014.
She was the Chief Financial Officer at STAAR Surgical Co. from 2017 to 2020.
Prior to that, she worked as an Auditor at KPMG Peat Marwick LLP from 1991 to 1994, and as an Internal Auditor at Bourns, Inc. from 1994 to 1995.
She also served as the Vice President-Finance at STAAR Surgical AG in 2001.
Andrews completed her undergraduate degree from California State University-San Bernardino.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-07-19 15,578 ( 0.01% ) 17 292 $ 2024-04-29

Deborah J. Andrews active positions

CompaniesPositionStart
LINEAGE CELL THERAPEUTICS, INC. Director/Board Member 2014-04-10
All active positions of Deborah J. Andrews

Former positions of Deborah J. Andrews

CompaniesPositionEnd
STAAR SURGICAL COMPANY Director of Finance/CFO 2020-07-05
Director of Finance/CFO 2000-12-31
Comptroller/Controller/Auditor 1994-12-31
KPMG Peat Marwick LLP Comptroller/Controller/Auditor 1993-12-31
See the detail of Deborah J. Andrews's experience

Training of Deborah J. Andrews

California State University-San Bernardino Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Deborah J. Andrews's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
STAAR SURGICAL COMPANY

Health Technology

LINEAGE CELL THERAPEUTICS, INC.

Health Technology

Private companies3
KPMG Peat Marwick LLP

Commercial Services

Producer Manufacturing

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Deborah J. Andrews
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW